Atlas Capital Advisors Inc. Invests $1.85 Million in Cardinal Health, Inc. $CAH

Atlas Capital Advisors Inc. bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 9,020 shares of the company’s stock, valued at approximately $1,854,000.

A number of other institutional investors have also modified their holdings of the company. Redhawk Wealth Advisors Inc. grew its holdings in shares of Cardinal Health by 0.5% during the 4th quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock worth $1,902,000 after purchasing an additional 48 shares during the period. HF Advisory Group LLC grew its holdings in shares of Cardinal Health by 0.9% during the 4th quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock worth $1,074,000 after purchasing an additional 49 shares during the period. Hillsdale Investment Management Inc. grew its holdings in shares of Cardinal Health by 0.9% during the 4th quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock worth $1,184,000 after purchasing an additional 50 shares during the period. Generali Asset Management SPA SGR grew its holdings in shares of Cardinal Health by 11.0% during the 4th quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock worth $105,000 after purchasing an additional 51 shares during the period. Finally, Stephens Inc. AR grew its holdings in shares of Cardinal Health by 0.9% during the 4th quarter. Stephens Inc. AR now owns 5,951 shares of the company’s stock worth $1,223,000 after purchasing an additional 52 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CAH. Evercore decreased their target price on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a report on Wednesday, April 8th. TD Cowen increased their price objective on shares of Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research report on Friday, May 1st. Leerink Partners reiterated an “outperform” rating and set a $275.00 price objective on shares of Cardinal Health in a research note on Monday, March 9th. Citigroup reduced their target price on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Finally, William Blair assumed coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They set an “outperform” rating on the stock. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $246.93.

Cardinal Health Trading Up 1.2%

NYSE CAH opened at $223.76 on Friday. The company’s fifty day simple moving average is $203.21 and its 200-day simple moving average is $208.85. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $233.60. The stock has a market cap of $52.41 billion, a P/E ratio of 34.21, a PEG ratio of 1.22 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same period in the previous year, the company posted $2.35 earnings per share. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, research analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is currently 31.19%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.